drugset / Trial / NCT04448561
A Study to Assess the Safety, Tolerability and Pharmacokinetics of Multiple Doses of ASP8062 With a Single Dose of Morphine in Recreational Opioid Using Participants
Phase 1
Completed
24 enrolled
Astellas Pharma Global Development, Inc.
National Institute on Drug Abuse (NIDA) · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The primary purpose of this study was to assess the safety and tolerability of multiple doses of ASP8062 or placebo alone and in combination with a single dose of morphine. This study also assessed the potential for pharmacokinetic interaction between ASP8062 and morphine.
Timeline
- Start
- 2020-06-30
- Primary completion
- 2020-09-11
- Completion
- 2020-09-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ASP8082 | Unknown | — | Oral |
| Subject | Morphine | Other / unclassified | — | Oral |